In the United States alone, an estimated 6.7 million adults over the age of 20 are living with heart failure, and approximately 805,000 people experience a heart attack each year—about one every 40 seconds. American Heart…
Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…
Each year, nearly 20 million people worldwide are diagnosed with cancer, a number projected to rise sharply in the coming decades. For patients and families, a diagnosis often brings uncertainty, difficult treatment decisions, and limited options—particularly…
Thyroid disorders are among the most common endocrine conditions, affecting nearly 20 million Americans. Women are 5–8 times more likely to develop thyroid-related issues, with one in eight women experiencing a condition during their lifetime. Symptoms…
January is Cervical Cancer Awareness Month, a time to highlight a disease that continues to affect thousands of women each year despite being largely preventable, with new cases ranging from about 12,500 in 2021 to an…
“As we close 2025, I’m incredibly proud of what the TrialX team has built over more than 17 years of innovation and delivery. From launching our first app in 2008 with pioneers like Google Health and…
2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S for a condition – introducing high-impact therapies that are redefining what “breakthrough” truly means. This year’s portfolio…
